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Abstract
Background: Orthopaedic procedures, such as total hip replacement and total knee replacement, are among the
commonest surgical procedures in England. The Getting it Right First Time project (GIRFT) aims to deliver
improvements in quality and reductions in the cost of NHS orthopaedic care across the country. We will examine
whether the planned changes have delivered improvements in the quality of care and patient outcomes. We will
also study the processes involved in developing and implementing changes to care, and professional and
organisational factors influencing these processes. In doing so, we will identify lessons to guide future improvement
work in other services.
Methods/design: We will evaluate the implementation of the GIRFT programme, and its impact on outcomes and
cost, using a mixed methods design. Qualitative methods will be used to understand the programme theory
underlying the approach and study the effect of the intervention on practice, using a case study approach. This will
include an analysis of the central GIRFT programme and local provider responses. Data will be collected via semi-
structured interviews, non-participant observation, and documentary analysis. Quantitative methods will be used to
examine ‘what works and at what cost?’ We will also conduct focus groups with patients and members of the
public to explore their perceptions of the GIRFT programme. The research will draw on theories of adoption,
diffusion, and sustainability of innovation; its characteristics; and contextual factors at provider-level that influence
implementation.
Discussion: We will identify generalisable lessons to inform the organisation and delivery of future improvement
programmes, to optimise their implementation and impact, both within the UK and internationally. Potential
challenges involved in conducting the evaluation include the phased implementation of the intervention in
different provider organisations; the inclusion of both retrospective and prospective components; and the effects of
ongoing organisational turbulence in the English NHS. However, these issues reflect the realities of service change
and its evaluation.
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Background
Orthopaedic procedures, such as total hip replacement
(THR) and total knee replacement (TKR), are among the
commonest surgical procedures in England [1]. Rates of
joint replacement have risen substantially over the past
decade [2], whilst orthopaedic referrals from primary to
secondary care have increased by 7–8% each year [1].
The first ‘Getting it Right First Time’ (GIRFT) report,
published in 2012, recommended changes to NHS ortho-
paedic practice to improve patient outcomes, and achieve
cost savings [1]. NHS England subsequently funded a ‘na-
tional professional pilot’ to be implemented by a project
team, hosted on behalf of the British Orthopaedic Associ-
ation (BOA), at the Royal National Orthopaedic Hospital
in Stanmore. Senior clinicians visited providers to offer
bespoke recommendations about improving care. A ‘dash-
board’ of clinical and financial performance data was
created for each provider organisation, to inform self-
assessment of local services. By July 2015, the GIRFT pro-
ject team had carried out reviews with 120 NHS Trusts in
England. The project highlighted significant variations in
practice and outcomes; device and procedure selection;
costs; and infection rates [3].
Consequently, the Department of Health (DH) has
commissioned a £2.45m, three-year programme to ad-
dress these challenges initially in orthopaedics, and then
across ten other clinical specialities. Building on the visits
carried out during the professional pilot, the programme
consists of three additional implementation tools, each
acting at a different level: regular publication of provider-
level performance data via a dashboard (clinical level
intervention); tailored written feedback to underperform-
ing providers (top down intervention) and commissioning
levers to change behaviour (commissioner level interven-
tion). It seeks to change practice, (e.g. prosthesis choice)
in order to improve patient outcomes (e.g. infection rates).
Work is underway to enhance patient safety by increasing
minimum volumes of complex procedures undertaken by
individual surgeons. Regional networks will also be estab-
lished to increase minimum volumes of complex proce-
dures, and discussions are underway with NHS England
and NHS Improvement around improvements to the tariff
for purchasing, or commissioning, orthopaedic care. NHS
Improvement is currently responsible for overseeing orga-
nisations that provide NHS-funded care. Additionally,
involvement of relevant professional organisations, includ-
ing the British Orthopaedic Association (BOA) and the
Specialist Orthopaedic Alliance, is being used to encour-
age change. The programme also has strong links with
Lord Carter’s Procurement and Efficiency programme [4].
The GIRFT programme can thus be defined as a
‘complex intervention,’ containing several interacting
components, targeting different stakeholders and ad-
dressing a number of different behaviours [5]. There
is, however, limited evidence to support the proposed
approach. Best et al. suggest that the effectiveness of
feedback, for example via dashboards, is dependent
on the presence of incentives [6], whilst Turner et al.
emphasise the importance of a combination of both
system (top-down) and distributed (bottom-up) lead-
ership in enabling change [7]. Dixon-Woods et al.
also highlight the importance of both ‘hard’ and ‘soft’
incentives for changing behaviour [8]. Whilst there
have been reorganisations of a number of acute NHS
services in recent years [9, 10], there have been few
examples on this scale. Literature about the diffusion
of health care innovations highlights the need for
more research on the processes by which innovations
are initiated, implemented and sustained, and in what
contexts [6, 11].
This project aims to contribute to the development of
that evidence base by studying in depth the implementa-
tion of changes to orthopaedic services. The new DH-
commissioned programme, which commenced in Janu-
ary 2016, will continue the work trialled in the national
pilot. We will therefore evaluate the intervention as a
whole, including the pilot and the work currently being
planned. We will focus on outcomes directly relating to
patient care, for the commonest elective orthopaedic
procedures: THR and TKR [12]. Through this, we will
identify lessons to inform future service improvement
efforts. In line with Medical Research Council guidance
about the evaluation of complex interventions, key goals
will be to refine our current understanding of the
details and timing of the intervention, as well as the
programme theory underpinning its implementation, to
inform decisions about which impacts that should be
measured [5]. Programme theory sets out the rationale
and assumptions about the mechanisms that link an
intervention’s processes and inputs to outcomes.
Articulation of this theory helps improve the measure-
ment of the intervention’s impacts [13].
Aim and objectives
The aim of the proposed research is to evaluate the
implementation of a complex intervention, ‘the GIRFT
programme’, which seeks to improve the quality and
cost-effectiveness of NHS orthopaedic care in England.
In doing so, we will identify lessons to guide future
improvement work in other services.
We will use formative and summative evaluation
methods to:
1. Examine the key processes of - and factors
influencing - the ongoing development and
implementation of planned improvements to
orthopaedic services, nationally and locally, including
any unintended consequences;
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2. Assess whether the GIRFT programme has reduced
variations in orthopaedic practice and expenditure,
and improved patient outcome measures;
3. Estimate the economic impacts (e.g. cost savings)
of these changes; and
4. Explore patient and public perceptions of the
planned improvements to care.
Methods/design
To develop worthwhile lessons for improvement pro-
grammes in the future, it is important to establish not just
whether process and outcome changes took place, but also
how and why they occurred. We will therefore evaluate
the implementation of the GIRFT programme, and the
impact of specific interventions on outcomes and cost,
using a mixed methods design. As part of this, we will ex-
plore the interplay between the different implementation
tools, acting at different levels, and their impact on both
changes in practice and patient outcomes. The following
component studies, which are interdependent and will
inform one another, are planned in relation to each object-
ive. Qualitative methods will be used to understand the
details of the intervention, as well as the programme the-
ory underlying its implementation, and to study the effect
of the different ‘implementation tools’ intended to pro-
mote changes in practice (Study 1). The research will draw
on theories of adoption, diffusion, and sustainability of
innovation [11]; its characteristics [14]; and contextual fac-
tors at provider-level that influence implementation [15].
Quantitative methods will be used to examine ‘what works
and at what cost?’ (Studies 2 and 3). Details of the inter-
vention gathered in Study 1 will be used to inform the
choice of variables and outcomes for these studies. We
will also use qualitative methods to explore patient per-
ceptions of the planned improvements to orthopaedic care
(Study 4). Methods for data collection and analysis are
described separately for each study.
To bring together the findings of the four study com-
ponents, the proposed evaluation will make use of an
existing analytic framework that aims to identify key
components of major system change, and how they
might interact [16]. Drawing on key features of change
identified in the implementation literature, the frame-
work distinguishes between the ‘implementation ap-
proach;’ ‘implementation outcomes’ (i.e. the adoption of,
fidelity to, and sustainability of a given intervention);
and ‘intervention outcomes’ (e.g. changes in provision
of care or patient outcomes). It will enable us to study
the factors that influence implementation of the
GIRFT programme (including the nature of the inter-
vention and how its implementation is facilitated), and
the potential relationships between these and inter-
vention outcomes, allowing insights into the ‘black
box’ of implementation.
Study 1: Organisational study
To examine the nature and implementation of the
changes to orthopaedics, we will conduct a multi-level
organisational study of their planning and roll out, using
a case study approach [17]. This will include an analysis
of the central GIRFT programme and local providers’ re-
sponses. Case studies were chosen because this approach
allows complex phenomena to be studied in-depth, taking
into account both the case (here, organisations providing
orthopaedic services) and the context (professional and
organisational processes), as well as interactions between
the two [17]. The research will focus on the potential
implementation tools used to promote change, which are
likely to be (1) performance review visits by a senior clin-
ician; (2) performance feedback via ‘dashboards’; (3) letters
from the GIRFT project team and other national stake-
holders recommending changes to practice, and (4) intro-
duction of ‘best practice’ tariffs for the purchasing of
orthopaedic care and related commissioning levers.
Using objective criteria, the evaluation team will iden-
tify six case study sites through discussion with the
GIRFT project team. Purposive sampling within groups
will be used to select: different types of hospital (e.g.
district general hospital versus teaching hospital); and
different settings (e.g. urban versus rural). Representa-
tives of the wider local health economy will be inter-
viewed where relevant (e.g. clinical commissioning
groups (CCGs)). As some for-profit providers with ‘Any
Qualified Provider’ (AQP) contracts are not part of the
general GIRFT programme, they will also be compara-
tors: representatives of two to three providers will be
interviewed to gain their perspective on implementing
improvement in orthopaedics. We will identify AQPs
providing elective orthopaedic services using internet
searches, including the NHS choices website. The selec-
tion criteria we apply will ensure the providers sampled
reflect different geographies (region of England and
urban/rural).
Data will be collected through semi-structured inter-
views, non-participant observation, and documentary
analysis. We will carry out semi-structured interviews
and observations at both national (e.g. the GIRFT pro-
ject team, including understanding and co-developing
the ‘programme theory’) and local levels (e.g. providers’
responses to the implementation tools and perceived
impact of the approach to implementation, and the
tools, on practice). Through the interviews we will
examine stakeholders’ perceptions of barriers and facili-
tators to change. We will also explore at provider level
the relationships between the implementation tools,
local organisational context, and programme uptake. We
anticipate conducting around 70 interviews, 100 h of
observations, and analysing relevant documents (e.g.
communications with providers). Repeat interviews with
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providers and the GIRFT project team will be conducted
a year apart to assess the impact of the programme over
time. A list of interviews is provided in Table 1.
Examples of non-participant observations at the na-
tional level will include attending the GIRFT project
team’s planning meetings, as well as dissemination and
educational events. Observations at the provider level
will include attending one-to-one feedback sessions pro-
vided by the GIRFT project team and locally initiated
responses to change, e.g. performance improvement
forums organised around the ‘dashboard’ and other
implementation tools.
We will also collect documentation about the GIRFT
programme at both national and local level in order to
capture how the programme is planned, communicated
to providers, and local responses from providers. These
documents will cover how the programme was devel-
oped and the processes of implementation (e.g. GIRFT
programme documentation; meeting minutes; letters
and other communications with providers; performance
reports; dashboards; and local providers’ documented
responses to the programme). Project documentation
will be collected over the lifespan of the evaluation. It
will inform the planning and conduct of the interviews
and non-participant observations in Study 1, as well as
the proposed quantitative analysis (Study 2).
Interviews will be digitally recorded for professional
transcription in full. Field journals for recording notes
will be kept by the researchers. Data will be analysed
thematically, combining inductive (ideas emerging from
the empirical data) and deductive approaches (with
reference to the innovations and implementation litera-
ture) [18]. Initial analysis and category building will be
conducted by the researchers and will include category
mapping and constant comparison. Cross case compari-
son will be used to compare and contrast findings at dif-
ferent levels within the same case study (e.g. differences in
the response of senior executives and service level within
providers) and the same level across different case studies
(e.g. variation in responses of providers, role of CCGs).
Validity will be assessed in relation to Patton’s four criteria
of validity in qualitative research: verification, rival expla-
nations, negative cases and triangulation [19]. Analysis of
documentary evidence will focus on documents covering
planning, events and progress of the GIRFT programme,
to build an understanding of the development and imple-
mentation of the programme and providers’ responses, as
well as identifying events that may have influenced pro-
gress of the work.
Study 2: Quantitative study
The quantitative analysis will examine the relationship
between the introduction and delivery of different com-
ponents of the ‘intervention’ (i.e. the implementation
tools) and intended changes to care processes and pa-
tient outcomes. The methods will be developed in detail
during the project and will draw on information about
the intervention gathered during the organisational
study (Study 1).
The quantitative analysis will be based on longitudinal
organisational data with NHS provider or hospital as the
primary unit of analysis. It will comprise (1) data from the
GIRFT project team that describe the implementation
tools and (2) process and outcome measures from linked
anonymised patient-level data from routine sources. The
analysis will seek to relate variation in the implementation
tools (independent variables) with changes in measures of
process and outcome (dependent variables). The final
choice of variables will be based on findings from the
multi-level organisational study (Study 1).
The three indicative implementation tools are likely to
comprise performance review visits by a senior clinician;
dashboard distribution; provider letters (both trust-
level); and tariff pricing levers (national). Details of the
interventions and their timing will be confirmed during
the Study 1 interviews with the GIRFT project team.
Table 1 List of interviews for organisational study (Study 1)
Level Round 1 interviews Repeat interviews Total Interviews
National level
GIRFT project team Clinical lead, programme manager, data analyst, Trust lead [n = 4] 2 6
GIRFT Provider Enablement Group Representatives of key stakeholders, e.g. NHS Improvement, British
Orthopaedic Association, NHS England, NHS litigation authority [n = 5]
2 7
Taskforces Up to three groups; interviews with chair and key members of group,
including commissioners [n = 8]
3 11
Provider level
Each provider site Up to six interviewees per provider, e.g. service manager, lead consultant,
middle manager, board member, e.g. MD or CEO. [n = 6x6 sites]
1 x6 sites 7x 6 sites
Comparators outside GIRFT
programme
2 providers (AQPs), interview with clinical and/or managerial lead from
each provider [n = 2]
2 4
Total 55 15 70
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However, implementation is likely to occur during the
period 2015–2017 and, in the case of dashboards and
letters, vary in timing between trusts.
Measures of process and outcome - the dependent
variables - are likely to be derived from routine linked
patient-level data (Hospital Episode Statistics (HES)
admitted patient care; National Joint Registry (NJR);
Public Health England surveillance data; and national
patient-reported outcomes (PROMs) programme for
elective surgery) and may comprise re-admission rates;
rates of revision surgery; surgical site infection; length of
stay; patient reported outcomes; type and cost of pros-
thesis; and surgeon/consultant volume. Information
about the use and cost of loan kits by providers will be
provided by GIRFT. In addition, linked patient-level data
will also provide information on potential confounders
such as socio-demographic characteristics (age, sex,
deprivation and ethnicity) and comorbidity. Data will be
linked at the patient level by an encrypted identifier
(encrypted HESID); no patient identifiable data will be
required. Information about surgeon volumes is included
in NJR data. It is anticipated that full data will cover the
period from April 2009, when England's national
PROMs programme started, to March 2018. Patient-
level data and trust-level data on interventions will be
linked by the HES trust provider code.
The approach to the analysis will also be dependent
on the findings of the multi-level organisational study
(Study 1). Descriptive analysis will map the timing and
duration of the implementation tools in trusts with the
periods of availability of linked patient-level data to iden-
tify differences in timing within trusts and the number
of monthly periods of pre- and post-implementation
patient-level data that will be available for analysis. It is
likely that the chosen analytical approach will involve
multivariable regression that tests for changes in trends
for the different process and outcome measures in re-
sponse to the interventions. Analyses will need to allow
for non-independence (e.g. at trust and/or surgeon
level); adjustment for potential confounding; specifica-
tion of modelled effect for intervention (e.g. change in
trend/step-change, wash-out period/delayed response);
and control. Control is likely to combine within-trust
control (before:after intervention) and potentially
between-trust control (differences in timing in interven-
tion sites and inclusion of non-intervention sites, e.g. in-
dependent providers of NHS orthopaedic surgery). Tariff
pricing levers, as a national intervention, will not allow
between-trust control. Interpretation of results will be
sensitive to the potential for residual confounding and
other methodological limitations, e.g. ‘contamination’ in
control sites.
A statistical analysis plan will be produced as part of
Study 2. The plan will determine the analytical approach
in greater detail and will draw on both the qualitative
study and initial mapping and analyses from the quanti-
tative study (variation, frequency and completeness of
proposed independent and dependent variables). In par-
ticular, the plan will consider the extent that it is possible
to differentiate between the impacts of the different imple-
mentation tools given their likely overlap in timing and
ensure that sufficient periods of post-introduction data are
available to allow an assessment of any impact. Initial ana-
lyses will examine data on the implementation tools and
on the process and outcome measures separately. Data
will only be combined once the analysis plan has been
approved by the study steering group. The timing of the
interventions and the availability of data within the time-
frame of the project will also determine which analyses
will be undertaken during the project. In the event that
the required data for this component of the evaluation are
not available during the lifetime of this grant, we will apply
for additional grant funding to continue the work.
Study 3: Economic study
To assess value for money, we will identify the difference
in costs and the difference in benefits of implementing
the GIRFT programme compared to the situation ‘in
absence of intervention,’ using a similar methodological
approach to that described above for Study 2.
Three main cost categories will be explored: (1) the
extra cost of GIRFT implementation tools (e.g. the cost
of performance review visits by a senior clinician); (2)
the extra cost incurred by providers to implement rec-
ommendations and sustain change (e.g. ring fenced
units); and (3) reduction in costs related to patient out-
comes (e.g. reduced expenditure on loan kits). Benefits
of the GIRFT programme could include health outcomes
for patients (e.g. reduced surgical site infections). The
GIRFT project team’s partnership with the NJR will
allow us to explore the relationship between implant
cost and effectiveness, measured by implant longevity
and revision rate.
Data on the following costs will be examined: (1) the
extra cost of GIRFT tools will be assessed using the data,
documents and invoices provided by the GIRFT project
team and where not available costed using marked
prices; (2) the extra cost incurred by providers to imple-
ment recommendations will be gathered directly from
Trusts or using data from the literature; (3) reduction in
costs related to outcomes will be assessed using NHS
costs, payment by results costs for length of stay, other
costs (for staff, consultations etc.) and data from litera-
ture where the above are not available.
Study 4: Patient and public focus groups
The planned improvements to orthopaedic care across
the country have been clinically led. To inform the
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development of future improvement programmes, we
will explore patient and public perceptions of the pro-
posed changes, and the desired outcomes. To do this,
we will conduct three focus groups, each with 6–8
participants. Two of the three groups (Groups 1 and 2)
will involve patients who have undergone an elective hip
or knee replacement in the two years prior to the start
of this study (Jan 2016–Jan 2018). Group 3 will include
patient representatives who have not undergone joint
replacement surgery, but who are in the age bracket
most likely to receive this type of intervention (age 60+)
[20]. As participants may not be aware of the proposed
changes to orthopaedics, the researchers will provide a
brief lay language overview of the GIRFT programme at
the start of each focus group.
Participants for Groups 1 and 2 will be recruited via
patient representative groups. This will include the
British Orthopaedic Association Patient Liaison Group
and groups within NIHR CLAHRC North Thames pro-
vider organisations in North Central and East London,
Bedfordshire, Essex and Hertfordshire. Group 3 will be
recruited via hospital based patient involvement groups,
and local organisations such as Health Watch in the
NIHR CLAHRC North Thames area.
During the focus groups, we will explore participants’
views about (1) the intended changes to practice and (2)
the intended improvements to patient outcomes. At the
start of the focus groups, the researchers will give partic-
ipants a brief overview of the planned changes to ortho-
paedics. Focus groups will be digitally recorded for
professional transcription in full. Fieldwork notes will
also be kept by the researcher. As in Study 1, data will
be analysed thematically, combining inductive and
deductive approaches [18].
Synthesis of quantitative and qualitative approaches
The qualitative and quantitative components of the
evaluation will be brought together in three ways. First,
a key goal of the organisational study (Study 1) is to
understand the programme theory underlying the
GIRFT approach. The findings will therefore directly
inform both the analytic design and final selection of
variables for the quantitative and economic studies
(Studies 2 and 3). Details of the intervention compo-
nents and their timing will also be confirmed during the
Study 1 interviews with the GIRFT project team.
Second, the dissemination of our findings will include
qualitative data about the implementation of the GIRFT
programme and patient/public perceptions of the inter-
vention, as well as quantitative data describing the
impact of specific interventions on outcomes and cost.
Finally, we will bring together the findings of all the
study components, using Fulop et al’s framework for
analyzing major system change [16]. This will enable us
to identify the key components of the GIRFT programme,
and the factors influencing its implementation, as well as
how these may have interacted.
Patient and public involvement
We have worked with the NIHR CLAHRC North
Thames Patient and Public Involvement/Engagement
Officer to seek the views of patients and the public on
the proposed evaluation, via the CLAHRC’s lay Research
Advisory Panel and the British Orthopaedic Association
Patient Liaison Group. Their feedback has been used to
refine the protocol and ensure appropriate consideration
of the patient perspective. Through this, we have identi-
fied three orthopaedic patients who have agreed to join
our Patient and Public Reference Group, together pro-
viding a range of perspectives on care. This group will
have a collaborative role in refining research design,
interpreting findings and disseminating results and will
meet physically three times, as well as being involved in
the interim via email/telephone/webinar. This will in-
clude ensuring that patient priorities are adequately
represented in Study 4, the patient focus groups. We will
provide training to members where necessary, as well as
appropriate reward and reimbursement for their contri-
bution and expenses incurred in taking part.
Discussion
In this protocol, we describe a proposed evaluation of
planned changes to NHS elective orthopaedic care in
England. The Getting it Right First Time project
(GIRFT) aims to deliver improvements in quality and
reductions in the cost of orthopaedic care across the
country. The approach will in due course be rolled out
across ten other NHS surgical specialities. We will con-
duct a mixed methods evaluation of the changes in or-
thopaedics, using formative and summative approaches.
Methods will include documentary analysis; one to one
interviews with a range of stakeholders; analysis of per-
formance and cost data; and focus groups with patients
and members of the public.
The organisational component (Study 1) will permit
the identification of factors that are influential in the
process of change, such as key obstacles to and enablers
of change at the professional and organisational level,
and how best to engage with these. The provider-level
case studies will also permit identification of both gener-
alisable and context-specific lessons. The quantitative
and economic studies (Studies 2 and 3) will describe
changes in the provision and cost of orthopaedic ser-
vices, and what impact these changes have on both the
organisation of care and patient outcomes. The patient
focus groups (Study 4) will enable us to describe the
views of patients and the public about service change of
this kind. Combining the qualitative and quantitative
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research elements, for example by using the findings of
the organisational study (Study 1) to inform the design
of the quantitative study (Study 2), will permit an exam-
ination of how change activities, contextual factors, and
outcomes interrelate.
The evaluation faces a number of wider methodological
and practical challenges.
First, the intervention was rolled out at slightly differ-
ent times in different provider organisations, as visits by
the GIRFT project team in the national professional
pilot took place in a phased way between September
2013 and July 2015 [3]. Therefore, as each provider or-
ganisation has different ‘before’ and ‘after’ phases, it is
possible that external factors might have influenced each
organisation differently. Also, conclusions drawn about
the relationship between the intervention and any im-
provements seen are less clear in ‘before’ and ‘after’ stud-
ies. It is possible that any improvements that occur
could have happened anyway and not as a direct result
of the policies implemented. Without randomisation, it
is also harder to rule out potential biases and gaming.
However, these complexities reflect the ‘real world’
nature of service change, and are thus commonly faced
in evaluations of this kind [21].
Second, the evaluation also includes both retrospective
and prospective components. This has the potential to
impact the organisational component of the research
(Study 2). For example, the planning and implementa-
tion of the national professional pilot was not observed
and interviewees’ recollection of events will naturally vary.
Ensuring suitable representation of stakeholders—based
on documentary analysis—and applying Patton’s validity
criteria [19] in the analysis will be key to ensuring that
important lessons are not missed.
Finally, the GIRFT programme has been implemented
during a period of significant turbulence in the NHS,
encompassing both the changes associated with the Health
and Social Care Act in 2013 and now a period of unprece-
dented financial challenge. However, our proposed methods
will allow us to capture some of the influences of such
turbulence, and how these might be dealt with when sus-
taining change. The distraction and uncertainty brought by
changes in associated organisations, such as commissioning
structures, is common in many settings, meaning the
research may have relevance in a wide range of settings.
In conclusion, this evaluation will provide an opportun-
ity to understand better what works, at what cost, as well
as how changes of this kind are implemented and sus-
tained. Reviews indicate that more research is needed to
understand drivers, processes, and outcomes when imple-
menting such large-scale changes [6, 11]. We will identify
lessons to inform the organisation and delivery of future
improvement programmes, both within the UK and inter-
nationally, to optimise their implementation and impact.
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